Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Aclarion, Inc. (NASDAQ:ACON) shares surged by approximately 53% in pre-market trading due to the grant of a U.S. patent for an MR spectroscopy system to diagnose intervertebral discs related to severe low back pain. Other stocks experienced significant movement in pre-market trading, with various gainers and losers listed, including AEye, Inc. (NASDAQ:LIDR), Applied UV, Inc. (NASDAQ:AUVI), and FedEx Corporation (NYSE:FDX), which saw a pre-market decline after reporting weaker-than-expected earnings and lowering its full-year revenue outlook.
December 20, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
FedEx Corporation shares fell 9.6% in pre-market trading after the company reported weaker-than-expected earnings for its second quarter and lowered its full-year revenue outlook.
Earnings misses and lowered revenue forecasts are typically seen as negative indicators for a company's financial health, leading to a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Aclarion, Inc. shares rose sharply by 53% in pre-market trading after being granted a U.S. patent for an MR spectroscopy system for diagnosing severe low back pain.
The grant of a new U.S. patent is a significant positive development for Aclarion, likely to increase investor confidence and perceived value, leading to a short-term rise in stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100